It's time to stop waiting around - and breathe life into patient engagement
A manifesto to make patient engagement as simple as ABC
Profitability in the Egyptian pharmaceutical industry remains constrained by tight price controls
Sharing her ''Living With'' research results, new patient insights columnist Mariel Melcalfe discusses biosimilar awareness
by David Laws
The days of seeing the pill as the value the industry provides is gone, stakeholders are demanding more from pharma than ever.
Rising drug prices have been hotly debated this year with a greater push for pricing transparency.
by Marc Yates
As growth begins to plateau in more established territories, attention is turning to emerging markets with a fast-expanding middle class.
3 ideas pharma should consider in modifying their commercial approach.